I
IMRX
Immuneering Corp
4.89
0.26+5.62%After Hours: 4.900 +0.010 +0.20%19:49 08/22 EDT
OPEN/PREV CLOSE4.680/4.630
TODAY RANGE4.502-4.980
VOL1.27M
MARKET CAP177.60M
52 WEEK RANGE1.010-4.980
AVG VOL (3M)1.39M
% TURNOVER3.49%
TURNOVER--
P/E (TTM)-3.2733
% RANGE10.31%
EPS(TTM)-1.4939
P/E(FORWARD)-3.4437
P/B4.205
BVPS1.163
DIVIDEND--
P/S4,050.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP134.68M
SHARES OUTSTANDING36.32M
NEXT EARNINGS--
FREE FLOAT27.54M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·1d ago
Immuneering Shares Gain on $25 Million Private Placement
TipRanks·1d ago
Immuneering prices 6.3M shares at $3.95 in private placement
Reuters·1d ago
IMMUNEERING ANNOUNCES $25 MILLION PRIVATE PLACEMENT
TipRanks·4d ago
Mizuho Securities Remains a Buy on Immuneering (IMRX)
Dow Jones·08/14 20:45
Immuneering Is Maintained at Buy by Chardan Capital
Dow Jones·08/14 20:45
Immuneering Price Target Maintained With a $13.00/Share by Chardan Capital
Benzinga·08/14 20:36
Chardan Capital Maintains Buy on Immuneering, Maintains $13 Price Target
TipRanks·08/14 20:35
Chardan Capital Reaffirms Their Buy Rating on Immuneering (IMRX)
TipRanks·08/14 04:04
Immuneering Corp. Reports Strong Trial Results and Patent Win
Benzinga·08/13 21:24
Immuneering Files For Mixed Shelf Of Up To $300M
Same Industry
Name/Symbol
Change%
Price